Antibody drug conjugates are biopharmaceutical compounds comprising a monoclonal antibody joined to a biologically active cytotoxic drug or cytotoxic agent. Unlike traditional chemotherapy, ADCs are designed to directly deliver cell-killing agents specifically to tumor cells while leaving healthy cells alone. This allows ADCs to eradicate cancerous cells while minimizing unwanted side effects in healthy tissues.
The global Antibody Drug Conjugates Market is estimated to be valued at ... Read more
